Boxer Capital, LLC’s Iteos Therapeutics Inc Com Position
Does Boxer Capital, LLC own Iteos Therapeutics Inc Com (2662247D)? Not currently — the last reported position was 2.95M shares worth $30M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.
Position Value
$30M
Q3 2024
Shares
2.95M
% of Portfolio
+1.48%
Quarters Held
17
position exited
Position History 2662247D
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2024 | 2.95M | $30M | +1.48% |
| Q2 2024 | 2.95M | $44M | +2.30% |
| Q1 2024 | 1.80M | $25M | +1.22% |
| Q4 2023 | 1.80M | $20M | +0.98% |
| Q3 2023 | 1.80M | $20M | +1.05% |
| Q2 2023 | 2.15M | $28,520 | +1.32% |
| Q1 2023 | 2.15M | $29,317 | +1.44% |
| Q4 2022 | 2.15M | $42M | +2.22% |
| Q3 2022 | 2.15M | $41M | +2.31% |
| Q2 2022 | 2.15M | $44M | +2.81% |
| Q1 2022 | 3.19M | $103M | +5.28% |
| Q4 2021 | 4.35M | $202M | +7.86% |
| Q3 2021 | 4.35M | $117M | +4.10% |
| Q2 2021 | 4.35M | $111M | +3.93% |
| Q1 2021 | 4.35M | $149M | +5.04% |
| Q4 2020 | 4.35M | $147M | +4.72% |
| Q3 2020 | 4.35M | $107M | +3.70% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of 2662247D.